1 Total failure PCR-unadjusted (Day 28); Sensitivity analysis |
2 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Subtotals only |
1.1 Primary analysis (Cochrane review) |
2 |
1720 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.60 [0.40, 0.90] |
1.2 Missing data included as failures |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.77 [0.58, 1.03] |
1.3 Missing data included as successes |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.61 [0.41, 0.90] |
1.4 Intention to treat analysis (of trial authors) |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.77 [0.58, 1.03] |
1.5 Per-protocol analysis (of trial authors) |
2 |
1683 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.66 [0.43, 1.01] |
2 Total failure PCR-adjusted (Day 28); Sensitivity analysis |
2 |
|
Risk Ratio (M-H, Fixed, 95% CI) |
Subtotals only |
2.1 Primary analysis (Cochrane review) |
2 |
1650 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.69 [0.56, 5.10] |
2.2 Missing or indeterminate PCR results included as failures |
2 |
1651 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.35 [0.49, 3.73] |
2.3 New infections included as successes |
2 |
1720 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.41 [0.51, 3.88] |
2.4 Missing data included as failures |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.06 [0.71, 1.57] |
2.5 Missing data included as successes |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.41 [0.51, 3.89] |
2.6 Intention to treat analysis (by trial authors) |
2 |
1807 |
Risk Ratio (M-H, Fixed, 95% CI) |
0.87 [0.60, 1.24] |
2.7 Per-protocol analysis (by trial authors) |
2 |
1676 |
Risk Ratio (M-H, Fixed, 95% CI) |
1.38 [0.50, 3.81] |